臨床外科79巻8号

2024年08月発行

特集 合併症を起こさない食道癌手術！—ハイボリュームセンターの技を学ぼう 食道癌術後合併症の現況

食道癌術後合併症と予後

著者： 坊岡英祐¹ 竹内裕也¹

所属機関： ¹浜松医科大学外科学第二講座

ページ範囲：P.845 - P.849

【ポイント】
◆食道癌術後合併症は有意に予後を悪化させる．
◆胸腔鏡下食道切除術やロボット支援食道切除術が急速に広まってきている．
◆救済手術（salvage surgery）や転向手術（conversion surgery）の安全性が向上し，施行される機会が増加してきている．

参考文献

1）日本食道学会（編）：食道癌診療ガイドライン2022年版，金原出版，2022

2）Kataoka K, Takeuchi H, Mizusawa J, et al：Prognostic Impact of Postoperative Morbidity After Esophagectomy for Esophageal Cancer：Exploratory Analysis of JCOG9907. Ann Surg 265：1152-1157, 2017

3）Booka E, Takeuchi H, Nishi T, et al：The Impact of Postoperative Complications on Survivals After Esophagectomy for Esophageal Cancer. Medicine（Baltimore）94：e1369, 2015

4）Booka E, Takeuchi H, Suda K, et al：Meta-analysis of the impact of postoperative complications on survival after oesophagectomy for cancer. BJS Open 2：276-284, 2018

5）van Hagen P, Hulshof MC, van Lanschot JJ, et al：Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366：2074-2084, 2012

6）Kato K, Ito Y, Daiko H, et al：A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study. J Clin Oncol 40（suppl）：Abstract 238, 2022

7）Koyanagi K, Kato K, Ito Y, et al：Impact of preoperative therapy for locally advanced thoracic esophageal cancer on the risk of perioperative complications：Results from multicenter phase III trial JCOG1109. J Clin Oncol 39（suppl）：Abstract 162, 2021

8）Tachimori Y, Kanamori N, Uemura N, et al：Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 137：49-54, 2009

9）Takeuchi H, Ito Y, Machida R, et al：A Single-Arm Confirmatory Study of Definitive Chemoradiation Therapy Including Salvage Treatment for Clinical Stage Ⅱ/Ⅲ Esophageal Squamous Cell Carcinoma（JCOG0909 Study）. Int J Radiat Oncol Biol Phys 114：454-462, 2022

10）Yokota T, Kato K, Hamamoto Y, et al：A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer. Ann Surg Oncol 27：460-467, 2020

11）Watanabe M, Toh Y, Ishihara R, et al：Comprehensive registry of esophageal cancer in Japan, 2015. Esophagus 20：1-28, 2023

12）Kikuchi H, Endo H, Yamamoto H, et al：Impact of Reconstruction Route on Postoperative Morbidity After Esophagectomy：Analysis of Esophagectomies in the Japanese National Clinical Database. Ann Gastroenterol Surg 6：46-53, 2022

13）Okamura A, Endo H, Watanabe M, et al：Influence of patient position in thoracoscopic esophagectomy on postoperative pneumonia：a comparative analysis from the National Clinical Database in Japan. Esophagus 20：48-54, 2023

14）Biere SS, van Berge Henegouwen MI, Maas KW, et al：Minimally invasive versus open oesophagectomy for patients with oesophageal cancer：a multicentre, open-label, randomised controlled trial. Lancet 379：1887-1892, 2012

15）Takeuchi H, Ando M, Tsubosa Y, et al：A randomized controlled phase Ⅲ trial comparing thoracoscopic esophagectomy and open esophagectomy for thoracic esophageal cancer：JCOG1409（MONET trial）. J Clin Oncol 42（suppl）：Abstract 249, 2024

16）Suda K, Ishida Y, Kawamura Y, et al：Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position：technical report and short-term outcomes. World J Surg 36：1608-1616, 2012

17）van der Sluis PC, van der Horst S, May AM, et al：Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer：A Randomized Controlled Trial. Ann Surg 269：621-630, 2019

18）Yang Y, Li B, Yi J, et al：Robot-Assisted Versus Conventional Minimally Invasive Esophagectomy for Resectable Esophageal Squamous Cell Carcinoma：Early Results of a Multicenter Randomized Controlled Trial：the RAMIE Trial. Ann Surg, 2021